150 related articles for article (PubMed ID: 23826920)
1. Membrane and soluble forms of endoglin in preeclampsia.
Oujo B; Perez-Barriocanal F; Bernabeu C; Lopez-Novoa JM
Curr Mol Med; 2013 Sep; 13(8):1345-57. PubMed ID: 23826920
[TBL] [Abstract][Full Text] [Related]
2. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
[TBL] [Abstract][Full Text] [Related]
3. Review: the enigmatic role of endoglin in the placenta.
Gregory AL; Xu G; Sotov V; Letarte M
Placenta; 2014 Feb; 35 Suppl():S93-9. PubMed ID: 24252708
[TBL] [Abstract][Full Text] [Related]
4. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
[TBL] [Abstract][Full Text] [Related]
5. Soluble endoglin contributes to the pathogenesis of preeclampsia.
Venkatesha S; Toporsian M; Lam C; Hanai J; Mammoto T; Kim YM; Bdolah Y; Lim KH; Yuan HT; Libermann TA; Stillman IE; Roberts D; D'Amore PA; Epstein FH; Sellke FW; Romero R; Sukhatme VP; Letarte M; Karumanchi SA
Nat Med; 2006 Jun; 12(6):642-9. PubMed ID: 16751767
[TBL] [Abstract][Full Text] [Related]
6. Aetiology and physiopathology of preeclampsia and related forms.
Lorquet S; Pequeux C; Munaut C; Foidart JM
Acta Clin Belg; 2010; 65(4):237-41. PubMed ID: 20954461
[TBL] [Abstract][Full Text] [Related]
7. Transcription factors E2F1 and E2F3 are expressed in placenta but do not regulate MMP14.
Kaitu'u-Lino TJ; Hastie R; Cannon P; Nguyen H; Lee S; Hannan NJ; Tong S
Placenta; 2015 Aug; 36(8):932-7. PubMed ID: 26145228
[TBL] [Abstract][Full Text] [Related]
8. The role of endoglin and its soluble form in pathogenesis of preeclampsia.
Margioula-Siarkou G; Margioula-Siarkou C; Petousis S; Margaritis K; Vavoulidis E; Gullo G; Alexandratou M; Dinas K; Sotiriadis A; Mavromatidis G
Mol Cell Biochem; 2022 Feb; 477(2):479-491. PubMed ID: 34783962
[TBL] [Abstract][Full Text] [Related]
9. Placental expression of VEGF is increased in pregnancies with hydatidiform mole: possible association with developing very early onset preeclampsia.
Zhao M; Yin Y; Guo F; Wang J; Wang K; Chen Q
Early Hum Dev; 2013 Aug; 89(8):583-8. PubMed ID: 23522390
[TBL] [Abstract][Full Text] [Related]
10. New developments in the pathogenesis of preeclampsia.
Naljayan MV; Karumanchi SA
Adv Chronic Kidney Dis; 2013 May; 20(3):265-70. PubMed ID: 23928392
[TBL] [Abstract][Full Text] [Related]
11. MT-MMPs in pre-eclamptic placenta: relationship to soluble endoglin production.
Kaitu'u-Lino TJ; Tuohey L; Ye L; Palmer K; Skubisz M; Tong S
Placenta; 2013 Feb; 34(2):168-73. PubMed ID: 23261267
[TBL] [Abstract][Full Text] [Related]
12. Translational analysis of mouse and human placental protein and mRNA reveals distinct molecular pathologies in human preeclampsia.
Cox B; Sharma P; Evangelou AI; Whiteley K; Ignatchenko V; Ignatchenko A; Baczyk D; Czikk M; Kingdom J; Rossant J; Gramolini AO; Adamson SL; Kislinger T
Mol Cell Proteomics; 2011 Dec; 10(12):M111.012526. PubMed ID: 21986993
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress-induced S100B protein from placenta and amnion affects soluble Endoglin release from endothelial cells.
Tskitishvili E; Sharentuya N; Temma-Asano K; Mimura K; Kinugasa-Taniguchi Y; Kanagawa T; Fukuda H; Kimura T; Tomimatsu T; Shimoya K
Mol Hum Reprod; 2010 Mar; 16(3):188-99. PubMed ID: 19939849
[TBL] [Abstract][Full Text] [Related]
14. The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis.
Tal R
Biol Reprod; 2012 Jun; 87(6):134. PubMed ID: 23034156
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast.
Munaut C; Lorquet S; Pequeux C; Blacher S; Berndt S; Frankenne F; Foidart JM
Hum Reprod; 2008 Jun; 23(6):1407-15. PubMed ID: 18413304
[TBL] [Abstract][Full Text] [Related]
16. Glyceryl trinitrate inhibits hypoxia-induced release of soluble fms-like tyrosine kinase-1 and endoglin from placental tissues.
Barsoum IB; Renaud SJ; Graham CH
Am J Pathol; 2011 Jun; 178(6):2888-96. PubMed ID: 21641407
[TBL] [Abstract][Full Text] [Related]
17. Soluble endoglin (sEng) joins the soluble fms-like tyrosine kinase (sFlt) receptor as a pre-eclampsia molecule.
Luft FC
Nephrol Dial Transplant; 2006 Nov; 21(11):3052-4. PubMed ID: 16870672
[No Abstract] [Full Text] [Related]
18. YC-1 reduces placental sFlt-1 and soluble endoglin production and decreases endothelial dysfunction: A possible therapeutic for preeclampsia.
Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Tuohey L; Kaitu'u-Lino TJ
Mol Cell Endocrinol; 2015 Sep; 413():202-8. PubMed ID: 26159901
[TBL] [Abstract][Full Text] [Related]
19. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
Lim JH; Kim SY; Park SY; Yang JH; Kim MY; Ryu HM
Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525
[TBL] [Abstract][Full Text] [Related]
20. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
